Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on July 10, 2026

Jul. 10, 2026

Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 10, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 10, 2026

Top China Orthopedic Sports Medicine and Trauma Implant Suppliers for Vietnam’s Growing Healthcare Market

Indeterminate EIN Presswire

Jul. 10, 2026

ProcellaRX Adds MH Consulting & Advisory as Strategic Partner in Ascend Ecosystem

Indeterminate EIN Presswire

Jul. 10, 2026

Elevar Therapeutics Receives FDA Complete Response Letter for Combination of Rivoceranib and Camrelizumab as a First-line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

Indeterminate GlobeNewswire

Jul. 10, 2026

AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs

Indeterminate GlobeNewswire

Jul. 10, 2026

AB Science fait le point sur son programme clinique avec l’arrêt de certaines études cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques

Indeterminate GlobeNewswire

Jul. 10, 2026

Cosmos Health Launches Subscription Model

Indeterminate GlobeNewswire

Jul. 10, 2026

FDA Proposes Rule to Modernize Drug Manufacturing Registration

Indeterminate GlobeNewswire

Jul. 10, 2026

Microscopy Market to Grow from USD 8.81 Billion in 2025 to USD 11.44 Billion by 2031, at a CAGR of 5.5% – MarketsandMarkets™

Indeterminate GlobeNewswire

Jul. 10, 2026

AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments

Indeterminate GlobeNewswire

Jul. 10, 2026

Palisade Bio to Participate in the Leerink Partners Therapeutics Forum

Indeterminate GlobeNewswire

Jul. 10, 2026

Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity

Indeterminate GlobeNewswire

Jul. 10, 2026

PatchMD Adds a Topical Berberine Patch to Its Lineup

Indeterminate GlobeNewswire

Jul. 10, 2026

Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

Indeterminate GlobeNewswire

Jul. 10, 2026

Communiqué de presse : Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable

Indeterminate GlobeNewswire

Jul. 10, 2026

Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative

Indeterminate GlobeNewswire

Jul. 10, 2026

SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders

Indeterminate GlobeNewswire

Jul. 10, 2026

Dubai Health and Rush University System for Health Announce Strategic Collaboration to Advance Quality of Care

Indeterminate GlobeNewswire

Jul. 10, 2026

PubHive Recognized as Best AI-Powered Scientific Workflow Platform 2026 – UK

Indeterminate EIN Presswire